Autopsy report · NCT03826368

Hemp-Derived Botanical Dietary Supplementation During Recovery From Brain Injury

“Lack of initial funding after approval of study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Real Time Diagnostics Ventures INC

Sponsor type

Industry

Conditions

Traumatic Brain Injury

Interventions

Hemp-derived botanical dietary supplement

Participants

0

Trials that died the same way

• L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder
  “Study funding has not been established” (84% match in meaning)
• Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
  “Unable to obtain funding to initiate/complete study” (82% match in meaning)
• Study of EQU-001 for Uncontrolled Focal Onset Seizures
  “insufficient funding to complete the study” (82% match in meaning)
• Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
  “Could not obtain approval for the planned study with available funding” (81% match in meaning)
• Augmented Reality-based Telerehabilitation Platform for Patients With Stroke
  “Study did not receive funding” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.